Dermapharm Holding SE Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Dermapharm Holding SE stock has a consensus rating of "Buy" and an average price target of €50.38. The average 1-year stock price forecast is 6.06% higher than the current stock price, while the lowest is €44.00 (-7.37%) and the highest is €60.00 (+26.32%).

Price Target: €50.38 (+6.06%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	€44.00	€50.38	€48.75	€60.00
Change	-7.37%	+6.06%	+2.63%	+26.32%

Analyst Ratings

The average analyst rating for Dermapharm Holding SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	2	1	1
Hold	2	2	2	2	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Fabian Piasta Jefferies	Jefferies	Hold Maintains €34.00 → €44.00	Hold	Maintains	€34.00 → €44.00	-7.37%	May 27, 2026
Gerhard Orgonas Berenberg Bank	Berenberg Bank	Buy Maintains €44.00 → €60.00	Buy	Maintains	€44.00 → €60.00	+26.32%	May 14, 2026

Financial Forecast

Revenue This Year

1.21B

from 1.18B

2.56%

from 1.18B

Revenue Next Year

1.25B

from 1.21B

3.80%

from 1.21B

EPS This Year

2.65

from 2.56

3.63%

from 2.56

EPS Next Year

2.93

from 2.65

10.55%

from 2.65

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	960.09M	1.04B	1.15B	1.20B	1.18B	1.21B
Revenue Growth	18.78%	8.38%	10.59%	3.89%	-1.43%	2.56%
Gross Profit	610.22M	648.70M	704.14M	749.85M	765.74M	811.85M
Gross Margin	63.56%	62.34%	61.19%	62.73%	64.98%	67.18%
Operating Income	295.91M	282.72M	193.16M	222.07M	236.62M	246.08M
Net Income	209.58M	134.24M	62.37M	113.79M	132.41M	139.00M
EPS	-	-	-	-	2.56	2.65
EPS Growth	-	-	-	-	16.46%	3.63%
Forward PE	22.27	10.61	17.44	16.66	15.94	17.94
Dividend / Share	2.17	1.05	0.88	0.90	0.88	1.02
Dividend Growth	-	-51.61%	-16.19%	2.27%	-2.22%	15.45%
Free Cash Flow	127.86M	218.88M	106.43M	99.52M	100.96M	178.48M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	1.2B
Avg	1.2B
Low	1.2B

Revenue Growth

Revenue Growth	2026	2027	2028
High	4.7%
Avg	2.6%
Low	1.5%

EPS Forecast

EPS	2026	2027	2028
High	2.92
Avg	2.65
Low	2.43

EPS Growth

EPS Growth	2026	2027	2028
High	14.3%
Avg	3.6%
Low	-4.9%